Your browser doesn't support javascript.
loading
Central nervous system progression in advanced non-small cell lung cancer patients with EGFR mutations in response to first-line treatment with two EGFR-TKIs, gefitinib and erlotinib: a comparative study.
Li, Meng-Xia; He, Hao; Ruan, Zhi-Hua; Zhu, Yu-Xi; Li, Rong-Qing; He, Xiao; Lan, Bao-Hua; Zhang, Zhi-Min; Liu, Guo-Dong; Xiao, Hua-Liang; Wu, Yan; Zhu, Bo; Wang, Ge; Yang, Zhen-Zhou.
Afiliação
  • Li MX; Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, 10 Changjiang Zhilu, Daping Yuzhong District, Chongqing, 400042, People's Republic of China.
  • He H; Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, 10 Changjiang Zhilu, Daping Yuzhong District, Chongqing, 400042, People's Republic of China.
  • Ruan ZH; Department of Oncology, Southwest Hospital, Third Military Medical University, Chongqing, 400037, People's Republic of China.
  • Zhu YX; Department of Oncology, First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China.
  • Li RQ; Department of Radiation Oncology, First Affiliated Hospital of Kunming Medical University, Kunming, 650032, Yunnan, People's Republic of China.
  • He X; Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, 10 Changjiang Zhilu, Daping Yuzhong District, Chongqing, 400042, People's Republic of China.
  • Lan BH; Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, 10 Changjiang Zhilu, Daping Yuzhong District, Chongqing, 400042, People's Republic of China.
  • Zhang ZM; Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, 10 Changjiang Zhilu, Daping Yuzhong District, Chongqing, 400042, People's Republic of China.
  • Liu GD; Eighth Department, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing, 400042, People's Republic of China.
  • Xiao HL; Department of Pathology, Research Institute of Surgery, Daping Hospital, Third Military Medical University, Chongqing, 400042, People's Republic of China.
  • Wu Y; Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, 10 Changjiang Zhilu, Daping Yuzhong District, Chongqing, 400042, People's Republic of China.
  • Zhu B; Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, People's Republic of China.
  • Wang G; Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, 10 Changjiang Zhilu, Daping Yuzhong District, Chongqing, 400042, People's Republic of China.
  • Yang ZZ; Cancer Center, Research Institute of Surgery, Daping Hospital, Third Military Medical University, 10 Changjiang Zhilu, Daping Yuzhong District, Chongqing, 400042, People's Republic of China. yangzz1970@163.com.
BMC Cancer ; 17(1): 245, 2017 04 04.
Article em En | MEDLINE | ID: mdl-28376735
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neoplasias do Sistema Nervoso Central / Carcinoma Pulmonar de Células não Pequenas / Receptores ErbB Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neoplasias do Sistema Nervoso Central / Carcinoma Pulmonar de Células não Pequenas / Receptores ErbB Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article